Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT® (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Addictive Behavior | medication | Alcohol Use Disorder | Alcoholic Intoxication | Alcohol-Related Disorders | Alcoholism
Age: Between 21 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required